This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Vora JP, Van Schalkwyk C, Keech M.A cost comparison of a basal bolus regimen (insulin glargine and insulin glulisine) with a conventional pre-mixed insulin regimen in type 2 diabetes patients - the GINGER Study. 69th Annual Scientific Sessions of the American Diabetes Association: abstr. 451-P, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
Owens D, EVANS M, Carroll D, Keech M.Insulin glargine plus OHAs versus biphasic insulin in type 2 diabetes - a cost comparison. 69th Annual Scientific Sessions of the American Diabetes Association: 141 abstr. 527-P, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
Greiner R-A, Azoulay M, Brandle M.Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 and type 2 diabetes modeling the interaction between hypoglycemia and glycemic control in Switzerland. 69th Annual Scientific Sessions of the American Diabetes Association: 517-518 abstr. 2017-PO, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
EVANS M, Owens D, Carroll D, Keech M.Cost savings in type 2 diabetes with insulin glargine compared with insulin detemir in the UK. 69th Annual Scientific Sessions of the American Diabetes Association: 517 abstr. 2016-PO, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
Bretzel RG, Dippel F-W, Linn T, Neilson AR.Comparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO Trial with insulin glargine. 69th Annual Scientific Sessions of the American Diabetes Association: 315 abstr. 1197-P, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
Rights and permissions
About this article
Cite this article
Insulin glargine, a sweet choice for diabetes mellitus. Pharmacoecon. Outcomes News 582, 5–6 (2009). https://doi.org/10.2165/00151234-200905820-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905820-00010